Value-Added Specialist Hyloris Launches IPO

Proceeds Will Allow Firm To Focus On US 505(b)(2) Opportunities

IPO
Hyloris has today announced plans to launch an IPO • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business